Amylin, Lilly's Byetta Gets Stronger Safety Warning (Update1) - Bloomberg.com
Links shared publicly online about this topic.
- 1,631total visits
Amylin, Lilly's Byetta Gets Stronger Safety Warning (Update1) - Bloomberg.com
Amylin Pharmaceuticals Inc. and Eli Lilly & Co. said safety warnings were strengthened for their diabetes drug Byetta relating to the risks of pancreatitis and the medicine's use by patients with severe kidney disease.
View full resource at bloomberg.com
Tags: Urinary System, Kidney Disease, Disease and Condition, Drug, Pharma, Byetta, Eli Lilly and Company, Nephrology
Most Recently Shared on November 2, 2009 at 7:03 pm By:
RT @TomLamb: Amylin, Lilly’s Byetta Gets Stronger Safety Warning (10/30/09, Bloomberg) http://bit.ly/EGKWn
Advertisement
